European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

AstraZeneca AB, Södertälje, Sweden

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

AstraZeneca AB
Astra

Identification

Bvcom
Bolagsverket 5560117482
Sirul
Siren 480556562
Siret
Siret 48055656200019
Lei
636700ITSLXVAJVLAY33
EUID
SEBOLREG.5560117482

Address

151 85 Södertälje, Sweden

Corporate purpose

64.20
Activities of holding companies

The object of the company's activities is to engage in the manufacture of and trade in products for health care, medical care and health care, to engage in financial business, to own and manage real and movable property, including shares and participations in other companies, and to carry out other activities connected with any of the said lines of business.

Financials

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network

Publications

Year 2025 in Euipotm
129 trademark filings (123 wordmarks, 4 figurative marks, 2 word figurative marks): ADBALYA, APDELYZ, APIJUL, APJULI, ARPIDYME, ARPWUNVO, BEVPEAK, BEZVYDA, BOKEYDA, BYTIVITI, CADCLAS, CIRVENZY …
Year 2025 in Epobase
22 European patent filings: Methods of Treating Brain Tumours and Neuroblastomas …
Year 2025 in Dpmam
7 trademark filings: NEBUCHAMBER, OXIS TURBOHALER, PULMICORT …
Year 2025 in Hor
6 EU fundings (€642,130): Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies …
28 Mar 2025
Registered Design
20 Feb 2025
Registered Design
20 Feb 2025
Registered Design
31 Dec 2024 in Sat
State Aid (€5,000,000 - €10M): Energy tax on electricity consumed in the production process of industrial activities – reduction of the energy tax on electricity
Year 2024 in Euipotm
64 trademark filings (58 wordmarks, 4 figurative marks, 2 word figurative marks): ANZANCIFY, AVICEFTAZ, BALIEFA, CAZARRIA, CAZAVVIEN, CHARGIFY, CHARJIFY, ENBAQTA, ERVIKTOS, ETCAMAH, EVSTANZA …
Year 2024 in Hor
12 EU fundings (€2,275,873): Research in Europe and Diversity Inclusion …
12 Dec 2024
Registered Design
12 Dec 2024
Registered Design
Year 2024 in Epobase
23 European patent filings: Orally Disintegrating Tablets …
31 Dec 2023 in Sat
State Aid (€5,000,000 - €10M): Energy tax on electricity consumed in the production process of industrial activities – reduction of the energy tax on electricity
Year 2023 in Epobase
77 European patent filings: Compositions and Methods for Treating Alpha-Synucleinopathies …
Year 2023 in Euipotm
21 trademark filings (19 wordmarks, 1 figurative mark, 1 word figurative mark): AEROSPHERE, BIFORXI, BRAXIVO, BREZTREV, CAMGOFEX, CAMGOSERD, CAMIPLEG, CAMKARM, CAMKLOVRA, CONSTOIC, DECLARE …
Year 2023 in Hor
6 EU fundings (€587,419): INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE …
1 Sept 2023 in Fts
EU funding (€39,795): 101103234 - Chemskills - Chemskills: Enabling the Green and Digital Skills Transformation of the Chemical Industry
24 Feb 2023
Patent: Pharmazeutische Iressa Zusammensetzung Enthaltend ein Wasserlösliches Cellulosederivat
31 Dec 2022 in Sat
State Aid (€5,000,000 - €10M): Energy tax on electricity consumed in the production process of industrial activities – reduction of the energy tax on electricity
31 Dec 2022 in Sat
State Aid (€1,000,000 - €2,000,000): Prolongation and modification of SA.49893 (2018/N) - Tax exemption for non-food based biogas and bio-propane in heat generation
Year 2022 in Epobase
45 European patent filings: Methods of Treating Brain Tumours and Neuroblastomas …
Year 2022 in Euipotm
58 trademark filings (49 wordmarks, 6 figurative marks, 3 word figurative marks): ABILEDGE, ADPERANZA, AIRISFLO, AIRSIPRIA, AIRZUPRA, ASGOVIVUM, BRELLARO, BYAMPI, CALLIOPE, CASVIVIP, CAVIVA …
Year 2022 in Hor
6 EU fundings (€1,989,596): Decoding novel reaction chemistries in biocatalysis – Training Europe’s next visionaries for a sustainable future …
2 Feb 2022
Registered Design: Tablets
2 Feb 2022
Registered Design: Tablets
31 Dec 2021 in Sat
State Aid (€500,000 - €1,000,000): Prolongation and modification of SA.49893 (2018/N) - Tax exemption for non-food based biogas and bio-propane in heat generation
31 Dec 2021 in Sat
State Aid (€5,000,000 - €10M): Energy tax on electricity consumed in the production process of industrial activities – reduction of the energy tax on electricity
Year 2021 in Epobase
58 European patent filings: Lipocalin Mutein DRY Powder Formulation for Treatment of Asthma …
Year 2021 in Euipotm
56 trademark filings (51 wordmarks, 4 figurative marks, 1 word figurative mark): AKDINA, AKIATRA, AKTALEST, AKYTRIA, AMNAZ, APMETEM, APPEBB, ATORAVIL, BLIVIZA, BREEZTRI, BREZTREE, BREZTREO, BREZTRIO …
Year 2021 in Hor
6 EU fundings (€278,000): FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem …
23 Aug 2021
Patent: Zusammensetzungen zur Oralen Verabreichung mit Einem Triazolo [4, 5-D]Pyrimidin-Derivat
Year 2021 in Dpmam
6 trademark filings: MUPS, OXIS TURBOHALER, PULMICORT, SYMBICORT …
12 Feb 2021
Patent: Pharmazeutische Zusammensetzungen beinhaltend Kristallsalze von 7-Ä4-(4-Fluorophenyl)-6-isopropyl-2-Ämethyl(methylsulfonyl)aminoÜpyrimidin-5-ylÜ-(3R,5S)-3,5-dihydroxyhept-6-ensäure
31 Dec 2020 in Sat
State Aid (€5,000,000 - €10M): Prolongation of tax reduction on electricity for manufacturing
Year 2020 in Epobase
41 European patent filings: Methods for Increasing Forced Expiratory Volume in Asthmatics Using Benralizumab …
Year 2020 in Euipotm
48 trademark filings (36 wordmarks, 3 figurative marks, 9 word figurative marks): AIRELLUS, AIRFYDE, AIRPRUVE, AIRSEEKA, AIRSUPRA, AIRVIKTO, BRELINTA, BUDFOR TURBUFLOW, BUFORDA TURBUFLOW, DALIRESP …
26 Nov 2020
Patent: 8-[6-[3-(Amino)Propoxy]-3-Pyridyl]-1-Isopropyl-Imidazo[4,5-C]Quinolin-2-ON-Derivate ALS Selektive Modulatoren der Ataxia Telangiectasia Mutierten (ATM) Kinase zur Behandlung von Krebs
Year 2020 in Hor
10 EU fundings (€2,017,933): Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment …
Year 2020 in Euipods
6 registered designs
30 Apr 2020
Wordmark: “VAROMBEX“
31 Dec 2019 in Sat
State Aid (€5,000,000 - €10M): Prolongation of tax reduction on electricity for manufacturing
31 Dec 2019 in Sat
State Aid (€500,000 - €1,000,000): Extension and amendment of scheme N866 / 2006 - Tax exemptions for certain renewable energy sources used for heat generation
Year 2019 in Epobase
41 European patent filings: Cyclopropyl-Fused Pyrrolidine-Based Inhibitors of Dipeptidyl Peptidase IV and Their Pharmaceutical USE …
Year 2019 in Euipotm
22 trademark filings (21 wordmarks, 1 figurative mark): AIRCOMPASS, AIRQ, AIRQB, FASENRA PEN, KOSELUGO, KYSELUMA, ORIEMBO, REDICA, TRIBRIZI, TRIXEO, TRIXPI, VALTOPAZ, VOKESELU, VUTORAQ, XAKTEMA …
Year 2019 in Hor
15 EU fundings (€2,703,693): EU Patient- cEntric clinicAl tRial pLatform …
Year 2019 in Dpmam
14 trademark filings: ALVESCO, AXIAGO, Budoxis, ELEZZUM, OMNAIR, OMNARIS, Optan, POSSIA, TICANTO …
Year 2019 in Euipods
9 registered designs
3 Jul 2019 via Astrazeneca Dunkerque Production SCS
General partner: Astrazeneca Dunkerque Production SCS
6 May 2019
Patent: Orale Darreichungsform Enthaltend einen PDE-4 Hemmer ALS Wirkstoff und Polyvinylpyrrolidone ALS Hilfstoff
2 Mar 2019
31 Dec 2018 in Sat
State Aid (€5,000,000 - €10M): Prolongation of tax reduction on electricity for manufacturing
Year 2018 in Epobase
44 European patent filings: SNAr Process for Preparing Benzimidazole Compounds …
Year 2018 in Euipotm
117 trademark filings (107 wordmarks, 2 figurative marks, 8 word figurative marks): 2F, 3F, ANOFSA, ASARIEX, ASAXETA, ASPAXA, AXANUM, AZ, AZ1, AZ2, AZ3, AZ4, AZ5, BAMBEC, BAQISTREL …
Year 2018 in Dpmam
33 trademark filings: "XYLOCAIN", ALIRO, APTIN, BELIF, CARBOSTESIN, CERIMA, CLEVELOX, DIRICLEV, DIRYTMIN, EMLA, LOC-PAIN, MARCAIN, NAROPIN, POLYAMP, POLYAMP DUOFIT …
Year 2018 in Hor
5 EU fundings (€563,966): European Screening Centre; Unique Library for Attractive Biology …
Year 2018 in Dpmap
13 patent filings: Östrogen-Rezeptor-Modulatoren …
31 Dec 2017 in Sat
State Aid (€5,000,000 - €10M): Prolongation of tax reduction on electricity for manufacturing
Year 2017 in Epobase
35 European patent filings: Dispenser and Method for Entraining Powder in an Airflow …
Year 2017 in Euipotm
60 trademark filings (57 wordmarks, 2 figurative marks, 1 word figurative mark): ACELVI, ALOVICTRA, ALSUSTEZ, ARLISPO, ASTRA, BENPLEOS, BETALOC, BREKYNTRA, BREMZIR, BREZALYNX, CONOBER, CRANISTO …
Year 2017 in Dpmam
1 wordmark: ALMANZA, APTIN, DECELDA, GLEDEPA, HYPRENAN, Jectofer, LOGIMAT, MOBLOC, ONGLYZA, Ratacand, THEO-DUR, ZOLACOS …
Year 2017 in Hor
7 EU fundings (€263,659): Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections …
Year 2017 in Dpmap
27 patent filings: Macrocyclische MCL1-Inhibitoren zur Krebsbehandlung …
Year 2017 in Euipods
36 registered designs
Year 2016 in Dpmam
3 word figurative marks: ALVESCO, ANTRA, ANTRA MUPS, ATACAND, ATACAND PLUS, ATACAND ZIDD, Aptin-Duriles, Astrapharm, BAMBEC, BELMIG, BELOC, BRICANYL, BRYTAR, Beloc-Duriles, Bricanyl …
Year 2016 in Euipotm
48 trademark filings (44 wordmarks, 2 figurative marks, 2 word figurative marks): AEROSPHERE, AFIMPACT, AFSYMP, ALZURIC, AXENTAN, BAKALVIO, BRYSQENE, CALQUENCE, CEMACER, CERIMA, DUZALLO, EBEBRETH …
Year 2016 in Epobase
37 European patent filings: Pharmaceutical Compositions for USE in the Treatment of Chronic Obstructive Pulmonary Disease …
Year 2016 in Dpmap
35 patent filings: Pyrazolderivate ALS 5-Lipoxygenase-Aktivierende Proteinhemmer …
Year 2016 in Euipods
5 registered designs
Year 2016 in Hor
5 EU fundings (€527,319): Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 …
28 Sept 2016
Patent: Procedure for reducing basophil levels
Year 2015 in Epobase
25 European patent filings: Mono-Fluoro Beta-Secretase Inhibitors …
Year 2015 in Dpmam
38 trademark filings: ACCORDEON, APPEBB, CEMACER, DAS LEBEN IST ES WERT, DAXAS, DECELDA, EQUIDACENT, Eufilina, Euphyllin CR, Euphylline, FORXIGA, GLEDEPA, MEMBRA, METIZOK, MIPCOVI …
Year 2015 in Euipotm
102 trademark filings (99 wordmarks, 1 figurative mark, 2 word figurative marks): AEROPEARL, ANAPTIR, APLYXAR, ASYMBI, AVEZBI, BEVESPI AEROSPHERE, BIAVZA, BLENVYA, BLEXIR, BLYX, BRELLARO, BUVODIQ …
Year 2015 in Dpmap
61 patent filings: 1,3,4-Thiadiazol-Verbindungen und deren Verwendung in der Behandlung von Krebs …
Year 2015 in Hor
7 EU fundings (€2,424,513): Accelerated Early staGe drug diScovery …
Year 2014 in Euipotm
45 trademark filings (44 wordmarks, 1 word figurative mark): ADVATROL, ALLAZRIN, AMPLIXA, ARDECTO, BEVESPI, BEXANTA-SC, BEXANTASC, CAZAVI, DEKARTO, EDYNTOS, ELEPULM, EXANTA-SC, EXARTA-SC, GALIDARIS …
Year 2014 in Epobase
35 European patent filings: Chromenone Derivatives with Anti -Tumour Activity …
Year 2014 in Dpmam
100 trademark filings: ACCORDEON, ALIRO, ALMANZA, ANAPEIN, APPEBB, APTIN, AXIAGO, Aptin-Duriles, Astrapharm, BELIF, BETALOC, BETALOC ZOK, BRYTAR, Beloc-Duriles, Budoxis …
Year 2014 in Dpmap
26 patent filings: Chemische Verbindungen …
Year 2014 in Euipods
7 registered designs
1 Mar 2014 in Fts
EU funding (€215,956): Fluor21 : Synthesis, Structure and Function of Fluorinated Systems
Year 2013 in Euipotm
48 trademark filings (47 wordmarks, 1 figurative mark): A MEANINGFUL DIFFERENCE, ACCOMOVE, ARTIVIUM, ATANYEC, COMBENCIL, ESTEATIL, ETTIXARN, EXACANTA, EXANTASC, EXANTYA, EXARTASC, EXARTIN, FILCANTE …
Year 2013 in Dpmap
57 patent filings: Camsylat Salz des (1r,1'R,4R)- 4-Methoxy-5"-Methyl-6'-[5-(Prop-1-yn-1-yl)Pyridin- 3-yl]-3'H-Dispiro[Cyclohexan-1,2'-Inden-1'2'-Imidazol]-4"-Amin und kristalline Formen davon zur …
Year 2013 in Epobase
33 European patent filings: New NON-Ionic Surfactants for Solubilizing Poorly Soluble Molecules …
Year 2013 in Dpmam
22 trademark filings: ADEPRONA, DAXAS, Eufilina, Euphyllin CR, Euphylline, TRIGLOBE, TURBUVENT, Theophyllard …
Year 2013 in Fts
6 EU fundings (total €1,166,026): Cartardis …
Year 2013 in Euipods
11 registered designs
Year 2012 in Epobase
59 European patent filings: Mipo Inhibitors for the Treatment of Huntington's Disease and Multiple System Atrophy …
Year 2012 in Euipotm
18 trademark filings (15 wordmarks, 1 figurative mark, 2 word figurative marks): BCSS, BEXANTA, ELEVARDA, EXARTA, EXARTA PLUS, GEMINARA, ISPROVAR, MODEQUA, NEXIUM CONTROL, PROSTART, PRYZODA …
Year 2012 in Dpmam
23 trademark filings: ASTRA, EFFEXIS, EXALTA, EXANTA PLUS, FELCOZOK, GASTROGARD, GLOBACILLIN, LEACAIN, LEVOCAIN, LEYACAIN, LOFRICTOJECT, MIMITELA, MIXOBAR, MONOHALER, MONOLATOR …
Year 2012 in Dpmap
34 patent filings: Verfahren zur Herstellung von Benzyl-[(3AS,4R,6S,6AR-)6-Hydroxy-2,2-Dimethyltetrahydro-3AH-Cyclopenta-[D-][1,3-]Dioxol-]-4-YL-]Carbamat und Zwischenprodukte in Diesem Verfahren …
31 Jul 2012
Registered Design: Containers
31 Jul 2012
Registered Design: Containers
1 Jan 2012 in Fts
EU funding (€189,966): Development of Cytochrome P450 Enzymes for the Chemical Manufacturing Industries
Year 2011 in Epobase
71 European patent filings: Heterocyclic Inhibitors of MEK and Methods of USE Thereof …
Year 2011 in Euipotm
53 trademark filings (52 wordmarks, 1 word figurative mark): ALOGEMZA, AMBRIDEX, ARIMINOLVA, ARINOLVA, ARITAMON, ARITIMO, AXENTAN, BUDFOR, CESNORIN, CONFIDOSER, DEPODEX, DUCENDOV, EBYMECT, EFICAXAL …
Year 2011 in Dpmap
65 patent filings: Morpholinopyrimidine und Ihre Verwendung für Therapeutische Zwecke …
Year 2011 in Dpmam
349 trademark filings: ACCORDEON, ALIRO, ALMANZA, ANAPEIN, APTIN, ASTRA, AXIAGO, Aptin-Duriles, BELIF, BETALOC, BRYTAR, Beloc-Duriles, Budoxis, CEMACER, CERAGLO …
15 Apr 2011
Registered Design: Blister package
1 Mar 2011 in Fts
EU funding (€224,263): Integrating Research Training in Particle & Powder Technology to Deliver Efficient Products with High Functionality
1 Jan 2011 in Fts
EU funding (€226,937): Screentox
Year 2010 in Dpmap
44 patent filings: Fulvestrant Formulierung …
Year 2010 in Epobase
108 European patent filings: Hydantoin Derivatives as MMP Inhibitors …
Year 2010 in Dpmam
344 trademark filings (6 wordmarks, 1 figurative mark, 2 word figurative marks): ACCORDEON, ADEPRONA, ALIRO, ALMANZA, ANAPEIN, ANTRA, ANTRA MUPS, APPEBB, APTIN, ASTRA, ATACAND, ATACAND PLUS, ATACAND …
Year 2010 in Euipotm
25 trademark filings (21 wordmarks, 3 word figurative marks, 1 other mark): BETALOC ZOC, BETALOC ZOK, BRILINCA, BRILINTE, BRILIQUE, BRILYNTA, BRYLINTA, EDISTRIDE, ETURBOHALER, ETURBUHALER, EXANTIN …
Year 2010 in Fts
4 EU fundings (total €352,327): Pulmonary Imaging Network …
Year 2009 in Dpmap
28 patent filings: Pyridin-Verbindungen …
Year 2009 in Epobase
192 European patent filings: Pyrimidine Indole Derivatives for Treating Cancer …
Year 2009 in Euipotm
15 trademark filings (13 wordmarks, 2 word figurative marks): BONLOSEC, CATIVA, DYNALOSEC, EGLYZI, GERDQ, LOSIVA, OMVOCATE, PLIVURON, RIMBONIQ, SOFOTEC, VEKLIVOT, ZEMFIRZA, ZUTORIB …
Year 2009 in Dpmam
25 trademark filings (1 wordmark, 3 word figurative marks): ADNUMIC, BELNIF, CATIVA, DORAKIB, GARDETTE, IDELOSEC, Jectofer, KIBIMME, LINECTOR, LOGIHALER, LOSIVA, MACH-PACK, MEMBRA, NUMIHALER, OKIBIKA …
Year 2008 in Dpmap
20 patent filings: Pyrazinonderivate und Ihre Verwendung zur Behandlung von Lungenkrankheiten …
Year 2008 in Epobase
329 European patent filings: Cinnoline Compounds …
Year 2008 in Euipotm
139 trademark filings (135 wordmarks, 1 figurative mark, 2 word figurative marks, 1 other mark): ACDIJUR, ARFYZE, ARJENTEF, ARXONTIS, ASTRAZENECA, AVGLEO, BARKLONTIS, BEMAZAR, BERVETRAL, BEYZELRA …
Year 2008 in Dpmam
1 word figurative mark: ANAQIX, ANTRA IMPRA, ANTRA OPTUS, BILBON, Celspine, GCO, GOT, METSELEN, OBRIMOS, PRAMIL, PREFERID, PUDESONITE, Rebiox, TELAMRA, ZICANDA …
1 Jan 2008 as Astrazeneca in France
Segment clas­si­fi­ca­tion
Year 2007 in Epobase
331 European patent filings: Piperidine Derivatives for the Treatment of Obesity …
Year 2007 in Dpmap
18 patent filings: Retard-Zusammensetzungen und Verfahren zu ihrer Herstellung …
Year 2007 in Dpmam
51 trademark filings (2 wordmarks, 2 other marks): ABILATOR, ANTRA ALLIRADIC, ANTRA AQUINA, ANTRA ELIMBEC, ANTRA ELIMICOM, ANTRA ELIMSEC, ANTRA EXPYLOR, ANTRA HELIARA, ANTRA HEPYRA, ANTRA LIMINANT …
27 Jun 2007
Wordmark: “AFFORA“
29 May 2007
Wordmark: “FROM IDEAS TO ASSETS“
12 Jan 2007
Wordmark: “PROLENIV“
Year 2006 in Epobase
367 European patent filings: Inhaler …
Year 2006 in Dpmam
30 trademark filings (8 wordmarks, 2 word figurative marks): AIRPAC, COLLOC, DAS LEBEN IST ES WERT, DECELDA, DICLONEX, ECOVIA, GLEDEPA, IBREX, LOGIMAT, MEMBRA, NEBUNETTE, NOVOLIZER, ONGLYZA, OXIS …
Year 2006 in Dpmap
20 patent filings: 9-Substituierte 8-Oxoadeninverbindung …
Year 2006 in Euipotm
4 wordmarks: EXANTAN, FREVIA, VELIEF, ZALTRO
Year 2005 in Epobase
257 European patent filings: Pharmaceutical Formulation Comprising Iota-Carrageenan and AT Least ONE Neutral Gelling Polymer …
Year 2005 in Dpmap
21 patent filings: Neues Verfahren zur Herstellung Vonroflumilast …
Year 2005 in Dpmam
5 trademark filings: ACID-NSAID DISEASE, ACID-PYLORI DISEASE, ACID-REFLUX DISEASE, ANAPEINE …
28 Jun 2005
Wordmark: “NASOLVE“
21 Feb 2005
Wordmark: “ZOC“
20 Jan 2005 as Astrazeneca in France
Address · Legal form · Name: ASTRAZENECA
There are no publications matching your search.

Mentions

24 Nov 2025 in Ler
Direct parent
24 Nov 2025 in Ler
Ultimate parent
5 Dec 2024 in Rne
Reg­is­tra­tion: 20/01/2005 · Segment clas­si­fi­ca­tion · Corporate Purpose
18 Oct 2024 in Psc
Companies House - Persons with Significant Control
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "AstraZeneca AB, Södertälje, Sweden" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.